STERIS plc $STE Shares Bought by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC increased its holdings in STERIS plc (NYSE:STE) by 20.3% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 16,158 shares of the medical equipment provider’s stock after purchasing an additional 2,729 shares during the quarter. Nisa Investment Advisors LLC’s holdings in STERIS were worth $3,393,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. Western Wealth Management LLC bought a new stake in STERIS during the 1st quarter valued at $25,000. Elevation Wealth Partners LLC increased its holdings in shares of STERIS by 1,130.0% in the 2nd quarter. Elevation Wealth Partners LLC now owns 123 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 113 shares during the period. Meramec Financial Planners LLC purchased a new position in shares of STERIS in the 1st quarter valued at $33,000. Trust Co. of Vermont bought a new position in shares of STERIS in the 2nd quarter worth $41,000. Finally, Community Financial Services Group LLC raised its position in shares of STERIS by 50.0% in the 3rd quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 72 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling at STERIS

In related news, Director Mohsen Sohi sold 4,058 shares of the business’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total transaction of $956,795.24. Following the transaction, the director directly owned 24,305 shares in the company, valued at $5,730,632.90. The trade was a 14.31% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.12% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

STE has been the subject of a number of analyst reports. UBS Group decreased their price objective on STERIS from $275.00 to $270.00 and set a “buy” rating for the company in a research note on Friday, August 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of STERIS in a research note on Monday, August 24th. Piper Sandler reiterated an “overweight” rating and issued a $275.00 target price (up from $270.00) on shares of STERIS in a report on Friday, August 7th. Finally, Wall Street Zen lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 11th. Three analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $271.33.

STERIS Price Performance

Shares of STE opened at $232.27 on Friday. The company has a market cap of $22.65 billion, a price-to-earnings ratio of 28.39 and a beta of 0.92. STERIS plc has a twelve month low of $195.14 and a twelve month high of $269.44. The company has a quick ratio of 1.35, a current ratio of 1.91 and a debt-to-equity ratio of 0.23. The company has a 50 day moving average of $220.09 and a two-hundred day moving average of $218.16.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.49 by $0.10. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.49 billion. STERIS had a net margin of 13.34% and a return on equity of 14.34%. The business’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.34 earnings per share. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. As a group, analysts predict that STERIS plc will post 11.12 earnings per share for the current fiscal year.

STERIS Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Friday, September 4th were given a $0.69 dividend. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend was Friday, September 4th. This is a positive change from STERIS’s previous quarterly dividend of $0.63. STERIS’s payout ratio is 33.74%.

About STERIS

STERIS plc (NYSE: STE) provides products and services designed to support infection prevention, procedural care and the safe manufacture of healthcare and life sciences products. Its offerings include surgical equipment and operating-room solutions, sterilization and decontamination systems, endoscopy products, cleaning and disinfection technologies, and related consumable products.

The company also provides outsourced sterilization and laboratory services through its Applied Sterilization Technologies business.